What is the Sun Pharmaceuticals Industries Ltd share price today? The Sun Pharmaceuticals Industries Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1762.05 today. What is the Market Cap ...

Sun Pharmaceuticals Ltd. announced on Saturday that the US District Court of New Jersey has granted a preliminary injunction preventing it from launching its new drug, Leqselvi, until further legal ...

Rights Mar 16, 2016 Mar 17, 2016 May 12, 2015 Rights ratio: 5 share for every 116 held at a price of Rs 245.0 Rights Aug 23, 2012-Jul 14, 2011 Rights ratio: 1 share for every 7 held at a price of Rs ...

Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The Company works on innovation and new product ...

Sun Pharmaceutical Industries Ltd, India’s largest drugmaker, has long been a favourite among investors. However, recent challenges, including a market-wide sell-off and a setback in its ...

ICICI Pru Regular Savings Fund (G) 44.75 2,53,104 1.40 ICICI Pru Regular Savings Fund (IDCW-Q) 44.75 2,53,104 1.40 ICICI Pru Regular Savings Fund (IDCW-HY) 44.75 2 ...

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 4,27,297.56 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical ...

better infrastructure, and strategic collaborations with industry leaders like Tiruppur. Clarification Sought From Sun Pharma Advanced Research Company Ltd - 4 day(s) ago Clarification sought from Sun ...

New Delhi: Sun Pharmaceutical Industries Limited (Sun Pharma) and its subsidiary, Sun Pharma Laboratories Limited, have been slapped with hefty fines and penalties exceeding Rs 76 crore by the customs ...

Some of the OTC products sold by Sun Pharma are analgesics, antacids, skincare products, etc. Listing Pharma major Sun Pharma is listed on a number of Indian stock exchanges such as BSE ...

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.